Siemens scores access to PET data in deal with Blue Earth

By staff writers

October 21, 2022 -- Siemens Healthineers has inked a data-sharing deal with Blue Earth Diagnostics for access to anonymized radiohybrid prostate-specific membrane antigen (PSMA) F-18 rhPSMA-7.3 clinical data and images.

In an agreement with Blue Earth and the University Hospital of Technical University of Munich (TUM), Siemens plans to evaluate the data to enhance its analytics and artificial intelligence-based algorithms for prostate cancer for its PET/CT imaging software.

F-18 rhPSMA-7.3 is a radiotracer synthesized by researchers at TUM, and it is being developed by Blue Earth. The tracer is currently being studied in two multicenter phase III trials, the company said.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking